Drug recall
Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company…
FDA recall event 88505 · Class II · Eli Lilly & Company
Key facts
| Event ID | 88505 |
|---|---|
| Recall numbers | D-0773-2021 |
| Recalling firm | Eli Lilly & Company |
| Product type | Drugs |
| Products | Trulicity (dulaglutide), 0.75 mg/0.5 mL, 4 Single-Dose Pens per box, Rx only, Eli Lilly and Company, Indianapolis, IN 46285, NDC 0002-1433-80 |
| Classification | Class II |
| Status | Terminated |
| Voluntary or mandated | Voluntary: Firm Initiated |
| Reason for recall | Labeling: Label error on declared strength - autoinjector devices labeled as 0.75 mg / 0.5 mL actually contain 1.5 mg / 0.5 mL of product. |
| Initiation date | Aug 19, 2021 |
| Report date | Sep 1, 2021 |
| Termination date | Aug 7, 2023 |
| City | Indianapolis |
| State | IN |
| Country | United States |
| FEI number | 1819470 |
At a glance
- 1–9 Products in this recall
- 10–99 FDA inspections of this firm (FEI)
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA drug and product recalls
FDA enforcement reports list recalls of drugs, biologics, foods and other FDA-regulated products, classified by the potential health hazard.
Source: U.S. Food and Drug Administration (FDA), Enforcement Reports · Source date: